Profile data is unavailable for this security.
About the company
Biocure Technology Inc. is a biopharmaceutical company. The Company is engaged in development and commercialization of various biopharmaceutical technologies relating to uses of recombinant and ranibizumab. The Company is comprised of scientists specializing in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. In addition, the Company is developing Biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.
- Revenue in CAD (TTM)0.00
- Net income in CAD-1.42m
- Incorporated2007
- Employees--
- LocationBiocure Technology Inc300-1055 West Hastings StreetVANCOUVER V6E 2E9CanadaCAN
- Phone+1 (604) 609-7149
- Fax+1 (604) 609-7149
- Websitehttps://biocuretech.com/
More ▼
Mergers & acquisitions
Acquired company | since announced | Transaction value |
---|---|---|
Atriva Therapeutics GmbH | 50.00% | -- |
Data delayed at least 15 minutes, as of Sep 11 2023.